Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,692,271
  • Shares Outstanding, K 381,142
  • Annual Sales, $ 750,270 K
  • Annual Income, $ -8,870 K
  • EBIT $ 123 M
  • EBITDA $ 234 M
  • 60-Month Beta 1.29
  • Price/Sales 2.28
  • Price/Cash Flow 10.88
  • Price/Book 2.46

Options Overview Details

View History
  • Implied Volatility 77.05% ( +1.65%)
  • Historical Volatility 56.62%
  • IV Percentile 81%
  • IV Rank 46.34%
  • IV High 125.06% on 11/20/24
  • IV Low 35.59% on 08/21/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 91
  • Volume Avg (30-Day) 621
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 26,097
  • Open Int (30-Day) 24,247

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.04
  • Number of Estimates 5
  • High Estimate 0.05
  • Low Estimate 0.03
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.18 +6.09%
on 11/21/24
5.09 -12.77%
on 12/04/24
+0.13 (+3.02%)
since 11/20/24
3-Month
4.09 +8.56%
on 11/15/24
7.20 -38.38%
on 10/08/24
-2.47 (-35.75%)
since 09/20/24
52-Week
4.09 +8.56%
on 11/15/24
9.26 -52.05%
on 07/25/24
-1.85 (-29.41%)
since 12/20/23

Most Recent Stories

More News
Why GoodRx Holdings Stock Was Sinking This Week

The company is growing key fundamentals. However, the improvements weren't enough to impress the market.

GDRX : 4.44 (-1.11%)
GoodRx (GDRX) Q3 2024 Earnings Call Transcript

GDRX earnings call for the period ending September 30, 2024.

GDRX : 4.44 (-1.11%)
GoodRx (GDRX) Q2 2024 Earnings Call Transcript

GDRX earnings call for the period ending June 30, 2024.

GDRX : 4.44 (-1.11%)
3 Top Stocks Under $10 to Buy Instead of GameStop

Meme stocks such as GME and AMC have risen substantially this month. However, due to their weak fundamentals, these companies are high-risk investments.

GME : 29.82 (+2.83%)
AMC : 4.18 (+2.20%)
RDDT : 170.71 (+4.27%)
CTLP : 9.58 (+2.90%)
IMMR : 9.09 (+1.62%)
GDRX : 4.44 (-1.11%)
GoodRx (GDRX) Q1 2024 Earnings Call Transcript

GDRX earnings call for the period ending March 31, 2024.

GDRX : 4.44 (-1.11%)
Why GoodRx Surged Today

The prescription-drug upstart got an upgrade from Wall Street.

WFC : 70.34 (+2.16%)
GDRX : 4.44 (-1.11%)
KR : 61.85 (+1.46%)
Why GoodRx Stock Soared Today

The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.

KR : 61.85 (+1.46%)
GDRX : 4.44 (-1.11%)
GoodRx (GDRX) Q4 2023 Earnings Call Transcript

GDRX earnings call for the period ending December 31, 2023.

GDRX : 4.44 (-1.11%)
Why GoodRx Holdings Stock Dived by Nearly 19% Today

An unimpressive quarter featuring weak guidance led investors to hit the sell button.

GDRX : 4.44 (-1.11%)
GoodRx (GDRX) Q3 2023 Earnings Call Transcript

GDRX earnings call for the period ending September 30, 2023.

GDRX : 4.44 (-1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 4.81
2nd Resistance Point 4.72
1st Resistance Point 4.58
Last Price 4.44
1st Support Level 4.35
2nd Support Level 4.26
3rd Support Level 4.12

See More

52-Week High 9.26
Fibonacci 61.8% 7.28
Fibonacci 50% 6.67
Fibonacci 38.2% 6.06
Last Price 4.44
52-Week Low 4.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar